238 related articles for article (PubMed ID: 21232557)
1. Working memory span capacity improved by a D2 but not D1 receptor family agonist.
Tarantino IS; Sharp RF; Geyer MA; Meves JM; Young JW
Behav Brain Res; 2011 Jun; 219(2):181-8. PubMed ID: 21232557
[TBL] [Abstract][Full Text] [Related]
2. The D2-family receptor agonist bromocriptine but, not nicotine, reverses NMDA receptor antagonist-induced working memory deficits in the radial arm maze in mice.
MacQueen DA; Young JW
Neurobiol Learn Mem; 2020 Feb; 168():107159. PubMed ID: 31911198
[TBL] [Abstract][Full Text] [Related]
3. The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans.
Bartholomeusz CF; Box G; Van Rooy C; Nathan PJ
J Psychopharmacol; 2003 Mar; 17(1):9-15. PubMed ID: 12680735
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
[TBL] [Abstract][Full Text] [Related]
5. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats.
Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM
Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
8. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
Wilkerson A; Levin ED
Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
Ng GY; George SR
Eur J Pharmacol; 1994 Nov; 269(3):365-74. PubMed ID: 7895775
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
12. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
13. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Zackheim JA; Abercrombie ED
Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
[TBL] [Abstract][Full Text] [Related]
14. D1- versus D2-receptor modulation of visuospatial working memory in humans.
Müller U; von Cramon DY; Pollmann S
J Neurosci; 1998 Apr; 18(7):2720-8. PubMed ID: 9502829
[TBL] [Abstract][Full Text] [Related]
15. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
Kamei H; Kameyama T; Nabeshima T
Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
Gáborján A; Lendvai B; Vizi ES
Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940
[TBL] [Abstract][Full Text] [Related]
17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
O'Neill MJ; Hicks CA; Ward MA; Cardwell GP; Reymann JM; Allain H; Bentué-Ferrer D
Eur J Pharmacol; 1998 Jul; 352(1):37-46. PubMed ID: 9718265
[TBL] [Abstract][Full Text] [Related]
19. [Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states].
Al'perina EL; Gevorgian MM
Eksp Klin Farmakol; 2010 Jun; 73(6):2-4. PubMed ID: 20726342
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
